Who Supplies Oxaliplatin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Oxaliplatin exports, with 249+ registered manufacturers shipping to buyers across 123+ countries — yet a handful of companies dominate the shipments. FRESENIUS KABI ONCOLOGY LIMITED holds the largest share at 21.9% (export value: $10.2M). Close behind, JODAS EXPOIM PRIVATE LIMITED (5.4%, $2.5M). GLAND PHARMA LIMITED (4.7%, $2.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Oxaliplatin? Top Manufacturers & Their Buyers
Flow of Oxaliplatin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Oxaliplatin Supplier Network — Key Market Intelligence
The Oxaliplatin export market from India is led by FRESENIUS KABI ONCOLOGY LIMITED, which alone commands a 21.9% share, shipping $10.2M worth of product across 602 shipments. The second-largest exporter, JODAS EXPOIM PRIVATE LIMITED, contributes $2.5M (5.4%) to the overall market. Combined, the top two suppliers alone account for 27.3% of all Oxaliplatin exports, indicating a relatively concentrated supply base.
Across all 249 tracked manufacturers, the total Oxaliplatin export value stands at $46.6M from 3.1K shipments. The market average shipment value is $15.1K. The single largest buyer relationship in terms of trade value is FRESENIUS KABI DEUTSCHLAND GMBH, receiving $7.9M worth of product.
The combined buyer network spans 16 named purchasing companies, including FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI MALAYSIA SDN BHD, FRESENIUS KABI COLOMBIA SAS, FRESENIUS KABI THAILAND LTD, OOO JODAS EXPOIM and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Oxaliplatin exporter from India, with a market share of 21.9% and a total export value of $10.2M across 602 shipments. Their average shipment value of $17.0K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 77.2% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $7.9M across 465 shipments (77.2% of this supplier's total exports)
• FRESENIUS KABI MALAYSIA SDN BHD — $663.2K across 39 shipments (6.5% of this supplier's total exports)
• FRESENIUS KABI COLOMBIA SAS — $647.2K across 38 shipments (6.3% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $511.4K across 30 shipments (5.0% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $508.0K across 30 shipments (5.0% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED's per-shipment value of $17.0K is 12% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
2JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the second-largest Oxaliplatin exporter from India, with a market share of 5.4% and a total export value of $2.5M across 32 shipments. Their average shipment value of $78.5K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• OOO JODAS EXPOIM — $836.8K across 11 shipments (33.3% of this supplier's total exports)
• OOO JODAS EXPOIM — $768.2K across 10 shipments (30.6% of this supplier's total exports)
• OOO JODAS EXPOIM — $370.7K across 5 shipments (14.8% of this supplier's total exports)
• M/S. OOO JODAS EXPOIM.. — $278.9K across 4 shipments (11.1% of this supplier's total exports)
• M S OOO — $256.2K across 3 shipments (10.2% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $78.5K is 419% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
3GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the third-largest Oxaliplatin exporter from India, with a market share of 4.7% and a total export value of $2.2M across 20 shipments. Their average shipment value of $109.2K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
GLAND PHARMA LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MEITHEAL PHARMACEUTICALS — $912.7K across 8 shipments (41.8% of this supplier's total exports)
• FOSUN PHARMA USA INC — $508.0K across 5 shipments (23.3% of this supplier's total exports)
• XXITHXXL PXXRMAXXUTI — $423.6K across 4 shipments (19.4% of this supplier's total exports)
• XXSUNXXHARXX USXX IN — $339.0K across 3 shipments (15.5% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED's per-shipment value of $109.2K is 622% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
4SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Oxaliplatin exporter from India, with a market share of 4.2% and a total export value of $2.0M across 113 shipments. Their average shipment value of $17.4K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $962.2K across 55 shipments (48.8% of this supplier's total exports)
• PHARMACIE CENTRALE DES HOPITAUX — $422.9K across 24 shipments (21.5% of this supplier's total exports)
• MS SUN PHARMACEUTICA — $203.9K across 12 shipments (10.3% of this supplier's total exports)
• PHARMACIE CENTRALE DES HOPITAUX — $195.3K across 11 shipments (9.9% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $186.4K across 11 shipments (9.5% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $17.4K is 15% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
5ACCURE LABS PRIVATE LIMITED
ACCURE LABS PRIVATE LIMITED is the fifth-largest Oxaliplatin exporter from India, with a market share of 3.0% and a total export value of $1.4M across 78 shipments. Their average shipment value of $18.1K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PHARMACIE CENTRALE DES HOPITAUX — $665.2K across 37 shipments (47.1% of this supplier's total exports)
• NA — $315.3K across 17 shipments (22.3% of this supplier's total exports)
• To The Order — $209.9K across 12 shipments (14.9% of this supplier's total exports)
• BANQUE POPULAIRE BPC — $134.1K across 7 shipments (9.5% of this supplier's total exports)
• TO THE ORDER OF — $86.9K across 5 shipments (6.2% of this supplier's total exports)
Key Insight: ACCURE LABS PRIVATE LIMITED's per-shipment value of $18.1K is 20% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
6MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Oxaliplatin exporter from India, with a market share of 2.9% and a total export value of $1.3M across 12 shipments. Their average shipment value of $110.9K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MYLAN INSTITUTIONAL INC 2898 — $574.1K across 5 shipments (43.1% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC 2898 — $427.1K across 4 shipments (32.1% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC 2898 — $329.4K across 3 shipments (24.8% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $110.9K is 634% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Oxaliplatin Flows
Once Oxaliplatin leaves the manufacturing plants of companies like FRESENIUS KABI ONCOLOGY LIMITED and JODAS EXPOIM PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $46.6M. Germany absorbs the largest share at 21.5% ($10.0M), followed by Russia (13.9%) and United States (9.4%).
In Germany — the top destination — named importers include FRESENIUS KABI DEUTSCHLAND GMBH. In Russia, key buyers are OOO"JODAS EXPOIM", OOOJODAS EXPOIM, OOO JODAS EXPOIM.
This geographic spread reflects Oxaliplatin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Oxaliplatin Go? Top Importing Countries & Their Buyers
Trade flow of Oxaliplatin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany ranks as the first-largest destination for Oxaliplatin imports from India, with a total trade value of $10.0M across 362 shipments — representing a 21.5% share of all Oxaliplatin exports. The average shipment value of $27.7K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Oxaliplatin importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 100.0% ($10.0M) of this market's total imports.
• FRESENIUS KABI DEUTSCHLAND GMBH — $10.0M (100.0% of Germany's total)
Key Insight: Germany's per-shipment average of $27.7K (83% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Oxaliplatin imports from India.
2Russia
Russia ranks as the second-largest destination for Oxaliplatin imports from India, with a total trade value of $6.5M across 31 shipments — representing a 13.9% share of all Oxaliplatin exports. The average shipment value of $208.8K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Oxaliplatin importers in Russia: OOO"JODAS EXPOIM" is the largest buyer, accounting for 48.0% ($3.1M) of this market's total imports.
• OOO"JODAS EXPOIM" — $3.1M (48.0% of Russia's total)
• OOOJODAS EXPOIM — $1.0M (15.8% of Russia's total)
• OOO JODAS EXPOIM — $836.8K (12.9% of Russia's total)
Key Insight: Russia's per-shipment average of $208.8K (1281% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Oxaliplatin imports from India.
3United States
United States ranks as the third-largest destination for Oxaliplatin imports from India, with a total trade value of $4.4M across 24 shipments — representing a 9.4% share of all Oxaliplatin exports. The average shipment value of $182.8K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Oxaliplatin importers in United States: MEITHEAL PHARMACEUTICALS is the largest buyer, accounting for 20.8% ($912.7K) of this market's total imports.
• MEITHEAL PHARMACEUTICALS — $912.7K (20.8% of United States's total)
• MYLAN INSTITUTIONAL INC — $620.5K (14.1% of United States's total)
• MYLAN INSTITUTIONAL INC. — $574.1K (13.1% of United States's total)
Key Insight: United States's per-shipment average of $182.8K (1109% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Oxaliplatin imports from India.
4Thailand
Thailand ranks as the fourth-largest destination for Oxaliplatin imports from India, with a total trade value of $3.4M across 47 shipments — representing a 7.4% share of all Oxaliplatin exports. The average shipment value of $73.2K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Oxaliplatin importers in Thailand: FRESENIUS KABI (THAILAND) LTD is the largest buyer, accounting for 28.7% ($987.8K) of this market's total imports.
• FRESENIUS KABI (THAILAND) LTD — $987.8K (28.7% of Thailand's total)
• C M C L — $620.1K (18.0% of Thailand's total)
• FRESENIUS KABI THAILAND LTD — $511.4K (14.9% of Thailand's total)
Key Insight: Thailand's per-shipment average of $73.2K (384% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Oxaliplatin imports from India.
5Algeria
Algeria ranks as the fifth-largest destination for Oxaliplatin imports from India, with a total trade value of $2.9M across 61 shipments — representing a 6.3% share of all Oxaliplatin exports. The average shipment value of $47.9K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Oxaliplatin importers in Algeria: PHARMACIE CENTRALE DES HOPITAUX is the largest buyer, accounting for 80.3% ($2.3M) of this market's total imports.
• PHARMACIE CENTRALE DES HOPITAUX — $2.3M (80.3% of Algeria's total)
Key Insight: Algeria's per-shipment average of $47.9K (217% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Algeria is a key market for Oxaliplatin imports from India.
People Also Ask — Oxaliplatin Supplier & Trade Network
Who are the top suppliers of Oxaliplatin from India?+
Which companies buy Oxaliplatin from Indian manufacturers?+
Where does Oxaliplatin exported from India go?+
What is the market share of the top Oxaliplatin supplier from India?+
What is the average shipment value for Oxaliplatin exports from India?+
Is Oxaliplatin manufactured in India and exported globally?+
Which country imports the most Oxaliplatin from India?+
Who are the buyers of Oxaliplatin in Russia?+
How concentrated is the Oxaliplatin supplier market in India?+
How do I find verified buyers for Oxaliplatin in specific countries?+
Oxaliplatin Trade Network — Key Takeaways
- 1FRESENIUS KABI ONCOLOGY LIMITED is India's dominant Oxaliplatin exporter with a 21.9% market share and $10.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 249 suppliers collectively account for 42.1% of all tracked Oxaliplatin exports, with a combined trade value of $46.6M.
- 3Germany is the largest destination market, absorbing 21.5% of India's Oxaliplatin exports ($10.0M). Russia (13.9%) and United States (9.4%) follow.
- 4With 3.1K total shipments averaging $15.1K each, the Oxaliplatin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI MALAYSIA SDN BHD, OOO JODAS EXPOIM, OOO JODAS EXPOIM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 123 countries
Network value: $46.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Oxaliplatin.
- 2.Flow Mapping: 249 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,081 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 123 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,081 Verified Shipments
249 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists